Safety and Efficacy of Pramipexole and Bromocriptine Combined With L-dopa in Parkinson's Disease
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The objective of the study was to evaluate the efficacy and safety of SND 919 (pramipexole)
tablets administered in combination with L-dopa in patients with Parkinson's disease using
placebo and bromocriptine tablets as comparators in a double-blind design (phase III
comparative study).